LHRH agonists provide an additional class of agents for treatment of premenopausal women with hormone-receptor-positive breast cancer. Optimum duration of use is unknown.

• LHRH激动剂为激素受体阳性的绝经前乳腺癌女性患者提供了一种附加的治疗手段。最佳服用时限仍未知。